JOURNAL ARTICLE

How antidepressants can help you manage depression and find relief from persistent sadness.

  • Published In: Fortune.com, 2023. P. N.PAG 1 of 3

  • Database: Business Source Ultimate 2 of 3

  • Authored By: Helmer, Jodi 3 of 3

Abstract

The article focuses on the treatment of depression in the United States, highlighting the significant increase in depression and anxiety during the COVID-19 pandemic and the role of antidepressants in managing these conditions. It discusses various classes of antidepressants, including selective serotonin reuptake inhibitors (SSRIs), serotonin-noradrenaline reuptake inhibitors (SNRIs), bupropion, tricyclic antidepressants (TCAs), and monoamine oxidase inhibitors (MAOIs), detailing their mechanisms of action, effectiveness, and potential side effects. The article emphasizes the importance of personalized treatment approaches and the need for ongoing research into new therapies, while also addressing the stigma surrounding mental health treatment. [Extracted from the article]

Additional Information

  • Source:Fortune.com. 2023/03, pN.PAG
  • Document Type:Article
  • Subject Area:Health and Medicine
  • Publication Date:2023
  • Accession Number:162704321
  • Copyright Statement:Copyright of Fortune.com is the property of Fortune Media (USA) Corporation and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Looking to go deeper into this topic? Look for more articles on EBSCOhost.